Patents/Inventors

Samuel Davis

New York, NYUS16 patents

14 Patents

US125288512026
Il2-based Therapeutics and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US125095142025
Antibodies Comprising Chimeric Constant Domains
Regeneron Pharmaceuticals, Inc.
0 cites
US125095162025
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors
Regeneron Pharmaceuticals, Inc.
0 cites
US123917532025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US123311092025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US122151482025
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US121802722024
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US121686812024
Il-2 Variants with Reduced Binding to IL-2 Receptor Alpha and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US121577582024
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
Regeneron Pharmaceuticals, Inc.
0 cites
US120901932024
Glucagon-like Peptide 1 Receptor Agonists and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US119650202024
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites
US118344852023
IL-2 Variants with Reduced Binding to IL-2 Receptor Alpha and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US117796332023
Glucagon-like Peptide 1 Receptor Agonists and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US117084072023
Antigen Binding Molecule Formats
Regeneron Pharmaceuticals, Inc.
0 cites